Clinical Trials on Wet Age-related Macular Degeneration in Norway
Total 144 results
-
Oslo University HospitalCompletedNeovascular Age-related Macular DegenerationNorway
-
BayerCompletedWet Age-related Macular DegenerationCanada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
-
AbbVieAbbVieEnrolling by invitationGene Therapy | AMD | nAMD | Wet AMD | Neovascular Age-Related Macular Degeneration (nAMD) | wAMDUnited States
-
SandozCompletedNeovascular Age-related Macular Degeneration (nAMD)United States
-
AffaMed Therapeutics (US) Inc.RecruitingNeovascular Age-related Macular DegenerationUnited States
-
EyePoint Pharmaceuticals, Inc.Active, not recruitingWet Age-related Macular DegenerationUnited States
-
Clearside Biomedical, Inc.Active, not recruitingNeovascular Age-related Macular DegenerationUnited States
-
Hoffmann-La RocheCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
Outlook Therapeutics, Inc.RecruitingAge-Related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular DegenerationUnited States
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Genentech, Inc.CompletedAge-related Macular DegenerationUnited States
-
AbbVieRecruitingCNV | AMD | nAMD | Wet AMD | Wet Age-related Macular Degeneration | wAMDUnited States
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, China, Czechia, Denmark, France, Hungary, Israel, Italy, Latvia, Slovakia, United Kingdom
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
LumiThera, Inc.RecruitingDry Age-related Macular DegenerationNorway
-
AbbVieRecruitingCNV | AMD | nAMD | Wet Age-related Macular Degeneration | wAMD | WetAMDUnited States, Puerto Rico, Canada
-
AbbVieAbbVieRecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States
-
Adverum Biotechnologies, Inc.ParexelActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, France, United Kingdom
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular DegenerationUnited States
-
Oslo University HospitalCompletedExudative Age-related Macular DegenerationNorway
-
MeddocOslo University HospitalCompletedAge-Related Macular Degeneration | Diabetic RetinopathyNorway
-
Sorlandet Hospital HFCompletedWet Macular DegenerationNorway
-
Kodiak Sciences IncCompletedWet Age-related Macular DegenerationUnited States, Puerto Rico
-
St. Olavs HospitalNorwegian University of Science and Technology; Alesund Hospital; Molde HospitalRecruitingWet Macular DegenerationNorway
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein OcclusionUnited States
-
Samsung Bioepis Co., Ltd.CompletedAge-Related Macular DegenerationKorea, Republic of, United States, India, Germany, Hungary, United Kingdom, Czechia, Poland, Russian Federation
-
Genentech, Inc.RecruitingAge-Related Macular DegenerationFrance, Germany, Israel, United States, Australia, Puerto Rico, Italy
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationFrance, Israel, Italy, United States, Spain, Portugal, Germany, Austria, Canada, Czechia, Estonia, Latvia, Poland, Slovakia, Australia, Hungary, Croatia, Argentina, Finland, Brazil, Colombia, Norway
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, France, Spain, Australia, Poland
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsEnrolling by invitationAge Related Macular Degeneration (AMD)United States, Germany, Spain, France, Australia, United Kingdom
-
Ohr Pharmaceutical Inc.UnknownAge-related Macular DegenerationUnited States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingGeographic Atrophy Secondary to Age-related Macular DegenerationUnited States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
-
Apellis Pharmaceuticals, Inc.Recruiting
-
Hoffmann-La RocheCompletedWet Macular DegenerationUnited Kingdom, Germany, Japan, Netherlands, United States, Canada, Hungary, Italy, Mexico, Poland, Spain, Israel, Russian Federation, Switzerland, Turkey
-
Kodiak Sciences IncTerminatedWet Macular DegenerationGermany, United States, Latvia, Spain, Czechia, Poland, Slovakia
-
Genentech, Inc.TerminatedGeographic Atrophy | Macular Degeneration, Age-RelatedUnited States
-
Apellis Pharmaceuticals, Inc.CompletedGeographic AtrophyUnited States, France, Italy, Netherlands, Israel, Germany, United Kingdom, Spain, Australia, New Zealand, Poland, Brazil, Canada, Czechia
-
Genentech, Inc.TerminatedGeographic Atrophy | Macular Degeneration, Age-RelatedUnited States
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Netherlands, Germany, Belgium, Poland, Spain, Argentina, Australia, Hungary, Italy, Portugal, France, Turkey, Austria, Russian Federation, Mexico, Peru, Denmark, Slovakia, Sweden, Switzerland
-
Apellis Pharmaceuticals, Inc.CompletedGeographic AtrophyItaly, Germany, United States, Israel, United Kingdom, France, Canada, Czechia, Australia, Spain, Argentina, New Zealand, Poland, Brazil, Puerto Rico
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Germany, France, Turkey, Australia, Austria, Belgium, Canada, Denmark, Hungary, Italy, Poland, Slovakia, Spain, Switzerland, Portugal, Netherlands, Peru
-
Novartis PharmaceuticalsCompleted